Effects of levetiracetam on chronic neuropathic pain following spinal cord injury: a randomized, double-blind, placebo-controlled, cross-over, multi-center study

Trial Profile

Effects of levetiracetam on chronic neuropathic pain following spinal cord injury: a randomized, double-blind, placebo-controlled, cross-over, multi-center study

Completed
Phase of Trial: Phase IV

Latest Information Update: 03 Dec 2015

At a glance

  • Drugs Levetiracetam (Primary)
  • Indications Neuropathic pain
  • Focus Therapeutic Use
  • Most Recent Events

    • 25 Aug 2009 Actual number of patients (36) added as reported by ClinicalTrials.gov.
    • 25 Aug 2009 Actual end date (Dec 2008) added as reported by ClinicalTrials.gov.
    • 25 Aug 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top